Intravenous Hydrogen Peroxide for Chronic Pain: An Alternative Etiology and Treatment Plan for the Long-Standing Painful States

Stuart L. Weg

Former Address: Department of Anesthesiology, Bergen Region Medical Center, Paramus, USA Current Address: Patients Medical, New York, USA.

DOI: 10.4236/pst.2014.22012                

Abstract

Background: Anecdotal reports of improvement in chronic pain patients given oxidative therapy (OXT) in the form of Intravenous Hydrogen Peroxide (IVHP) led the author to try this therapy on intractable pain cases. Method: 54 intractable non-malignant pain cases selected at random (16 had spinal problems, 14 had Interstitial Cystitis, 8 had headaches and 16 with miscellaneous problems) each received an average of 9 weekly IVHP infusions of 250 ml 0.03% Hydrogen Peroxide. After 4 months of this therapy all patients were given a questionnaire to evaluate and study any improvements in their condition. The questions covered three areas: 1) Subjective improvements: pain, function, mental and emotional status, general health, and sexual health, 2) Analgesic medication usage: dosage and efficacy changes, 3) Satisfaction with the therapy and desire to continue. Results: 52%-70% mean 66% of the patients responded positively (more than slightly improved) to questions in the subjective areas, 85% of the patients were using less medication and/ or getting more effect from the analgesics they were taking, 96% of the patients wished to continue the therapy. These improvements were constant over the range of the four diagnostic groups. The improved patients all demonstrated some signs and lab results including fever, chills, abscess formation, purulent discharges, elevated WBCs and ESRs consistent with resolving systemic and/ or regional infections. Conclusions: IVPH can significantly improve patients in a majority of chronic painful conditions. Chronic Infection is associated with or absolutely the cause of Chronic Pain in the patients studied.

Keywords

Intravenous Hydrogen Peroxide (IVHP), Chronic Pain, Oxidative Therapy (OXT), Infectious Disease

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Oliver, T.H., Cantab, B.C. and Murphy, D.V. (1920) Influenzal Intravenous Injection of Hydrogen Peroxide. Lancet, 1, 432-433. http://dx.doi.org/10.1016/S0140-6736(01)11118-9
[2]	Farr, C.H. (1987) The Therapeutic Use of Intravenous Hydrogen Peroxide (Monograph). Genesis Medical Center, Oklahoma City.
[3]	Lorinez, A.L., Jacoby, J.J. and Livingstone, M.M. (1948) Studies on the Parenteral Administration of Hydrogen Peroxide. Anesthesiology, 9, 162-174. http://dx.doi.org/10.1097/00000542-194803000-00006
[4]	Farr, C.H. (1989) Conference Presentation. First International Conference on Bio-Oxidativc Medicine. Dallas.
[5]	Farr, C.H. (1988) Possible Therapeutic Value of Intravenous Hydrogen Peroxide. Plzen.lek Sborn., Suppl. 56, 171-173.
[6]	McMinn, M. (1995) I.V. Hydrogen Peroxide Touted for Intractable Pain, Suggesting an Infectious Component. Anesthesiology News, 4.
[7]	Albert, H.B., Lambert, P., Rollason, J., Sorensen, J.S., Worthington, T. and Pedersen, M.B. (2013) Does Nuclear Tissue Infected with Bacteria Following Disc Herniations Lead to Modic Changes in the Adjacent Vertebrae? European Spine Journal, 22, 690-696. http://dx.doi.org/10.1007/s00586-013-2674-z
[8]	Albert, H.B., Manniche, C., Sorensen, J.S. and Deleuran, B.W. (2013) Antibiotic Treatment in Patients with Low-Back Pain Associated with Modic Changes Type 1 (Bone Oedema): A Pilot Study. European Spine Journal, 22, 697-707. http://dx.doi.org/10.1007/s00586-013-2675-y